News

Lupin inks agreement with Sino Universal for respiratory product in China
Lupin partners with SUP to commercialize Tiotropium DPI in China for COPD treatment, expanding respiratory care options.
Pharmabiz1h
Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China
Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China: Our Bureau, Mumbai Monday, June 16, 2025, 14:30 Hrs [IST] Global pharma major ...
Medical Dialogues4h
Lupin partners with SUP to bring Tiotropium DPI to COPD patients in China
Mumbai: Global pharma major Lupin Limited has signed a supply and license agreement with Sino Universal Pharmaceuticals (SUP) ...
CNBCTV184h
Lupin signs licence and supply agreement with Sino Universal Pharma for Tiotropium DPI in China
As per the agreement, SUP will obtain regulatory approvals for selling Tiotropium DPI in China, while Lupin will be the ...
Lupin Inks Pact with Sino Universal Pharma for Tiotropium DPI in China Market
Under the terms of the agreement, SUP will be responsible for obtaining the necessary regulatory approvals to sell Tiotropium ...
Physician's Weekly14h
Growing Overlap of COPD, Severe Obesity, and Sleep Apnea
The following is a summary of “Triple overlap of COPD, severe obesity, and high risk of OSA: insights from an NHANES analysis ...